Results 121 to 130 of about 1,960 (193)

PRURITUS CHARACTERISTICS IN A LARGE ITALIAN COHORT OF PSORIATIC PATIENTS. [PDF]

J Eur Acad Dermatol Venereol, 2019
Damiani G, Cazzaniga S, Conic RR, Naldi L, Psocare Registry Network.   +4 more
europepmc   +1 more source

Psoriatic arthritis and psoriasis: role of patient advocacy organisations in the twenty first century. [PDF]

Ann Rheum Dis, 2005
Zimmerman GM, Savage LM, Chandler DC, Maccarone Buonfigli M.   +3 more
europepmc   +1 more source

Litiuria e zincuria nella psoriasi

, 1983
Agar Monzani, Maurizio Coppini, Carlo Parenti, Maria Plessi, Dino Coppini   +4 more
openalex   +1 more source

56th annual Montagna Symposium on the Biology of Skin: Epidermal T-cell interactions--clinicopathological and basic mechanisms. [PDF]

J Invest Dermatol, 2008
Cooper KD, Sontheimer RD, Dutz J, Hwang ST, Nickoloff BJ, Shimada S, Kulesz-Martin M, Bickenbach JR.   +7 more
europepmc   +1 more source

Comportamenti stress-correlati, coping e caratteristiche psicofisiologiche nel pre e post trattamento PUVA in pazienti con psoriasi volgare

, 2013
Elena Carrozzo
openalex   +1 more source

Psoriasis Arthropathica [PDF]

Proceedings of the Royal Society of Medicine, 1931
openaire   +4 more sources

Chemosis as a presenting symptom of systemic lupus erythematosus. [PDF]

Lupus, 2010
Peponis V, Chalkiadakis S, Ergin S, Kyttaris VC.   +3 more
europepmc   +1 more source

Influenze delle caratteristiche psicologiche nel decorso, gestione e trattamento di soggetti affetti da psoriasi: uno studio esplorativo

, 2014
Edoardo Ercolini
openalex   +1 more source

Emerging role of interleukin-22 in autoimmune diseases. [PDF]

Cytokine Growth Factor Rev, 2013
Pan HF, Pan HF, Li XP, Zheng SG, Ye DQ.
europepmc   +1 more source

FK 506 - A new therapeutic agent for severe recalcitrant psoriasis [PDF]

, 1992
Abu-Elmagd, K, Ackerman, CD, Fung, JJ, Jegasothy, BV, Starzl, TE, Todo, S   +5 more
core